ArticleBMJ open2026
Impact of country income status on the relationship between interpregnancy interval and maternal complications of pregnancy: a systematic review and meta-analysis protocol.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBoth short and long interpregnancy intervals (IPIs) have been associated with adverse maternal outcomes, including uterine rupture, gestational diabetes mellitus (GDM), gestational hypertension and postpartum haemorrhage (PPH). However, the strength and consistency of these relationships remain uncertain, and there is limited information on how these associations differ according to country income status. This review is designed to examine the impact of the income status of a country on the relationship between IPI and maternal complications of pregnancy. METHODS AND ANALYSIS: CINAHL, MEDLINE, EMBASE via Ovid, Global Health, LILACS and African Index Medicus will be searched using combinations of MeSH and Emtree terms with keywords. Studies included are expected to be observational studies; existing systematic reviews with no new data will be excluded. The study population will consist of women with two or more singleton births and the exposure assessed will be short IPI (<24 months, <18 months and <12 months between the birth of a child and conception of the next pregnancy) and long IPI (>60 months). The comparator group will be an IPI of 24-60 months, as recommended by several international organisations. The co-primary outcomes are preterm pre-labour rupture of membranes, PPH, pre-eclampsia, gestational hypertension, GDM, uterine rupture and maternal mortality. The income status will be categorised according to the World Bank income-based classifications for low-, middle and high-income countries. Two reviewers will independently perform study screening, data extraction and risk of bias assessment using the Newcastle-Ottawa Score. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) framework will be used to assess the certainty of evidence. A random effects model will be used to calculate pooled ORs with 95% CIs. ETHICS AND DISSEMINATION: Ethics approval is not applicable for this study as no original data will be collected. The results will be disseminated through peer-reviewed publication and conference presentations. PROSPERO REGISTRATION NUMBER: CRD420251075283.Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251075283.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.